Search - tctmd.com

Displaying 701 - 720 of 911

Sort: Relevancy | Date

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

News Industry News

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

October 29, 2013

Presentation TCT 2013

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Presenter: Howard Herrmann

October 28, 2013

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Boston Scientific Receives CE Mark For Lotus™ Valve System

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

Presentation

Outcomes of Patients with Chronic Lung Disease and Severe Aortic Stenosis Treated with TAVR vs. Surgical Replacement or Standard Therapy

Presenter: D. Dvir

October 22, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

‘Obesity Paradox’ Observed in TAVR Patients

Caitlin E. Cox

October 15, 2013

News Industry News

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

September 17, 2013

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

News Daily News

Surgery Best for Long-term Management of Infants with Aortic Stenosis

August 23, 2013

News Daily News

European TAVR Usage Tied to Economics, Reimbursement

Yael L. Maxwell

July 12, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Industry News

Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

June 24, 2013

News Daily News

Drop in Platelet Count After TAVR Signals Poor Outcomes

Caitlin E. Cox

June 18, 2013

News Industry News

New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and Younger

June 17, 2013

Advertisement

Opportunities Exist to Improve Outcomes in Transapical TAVR

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

Mitral Regurgitation in Aortic Stenosis: How Often Is Surgical or Transcatheter Aortic Valve Replacement Effective?

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Boston Scientific Receives CE Mark For Lotus™ Valve System

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

PARTNER: La Enfermedad Pulmonar No es Barrera para la TAVR pero Aumenta el Riesgo de Mortalidad

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

Outcomes of Patients with Chronic Lung Disease and Severe Aortic Stenosis Treated with TAVR vs. Surgical Replacement or Standard Therapy

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

‘Obesity Paradox’ Observed in TAVR Patients

Boston Scientific Reports Favorable Six-Month Results from Lotus™ Valve System Clinical Trial

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Surgery Best for Long-term Management of Infants with Aortic Stenosis

European TAVR Usage Tied to Economics, Reimbursement

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

Drop in Platelet Count After TAVR Signals Poor Outcomes

New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and Younger

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content